SB
NMRA icon

SIG Brokerage’s Neumora Therapeutics NMRA Stock Holding History

SIG Brokerage’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.7K Hold
27,483
– – ﹤0.01% 896
2026
Q1 		$53.6K Sell
27,483
-5,663
-17% -$14.7K ﹤0.01% 758
2025
Q4 		$59.3K Sell
33,146
-2,265
-6% -$4.96K ﹤0.01% 645
2025
Q3 		$64.4K Hold
35,411
– – ﹤0.01% 717
2025
Q2 		$26K Hold
35,411
– – ﹤0.01% 675
2025
Q1 		$35.4K Buy
+35,411
New +$60.6K ﹤0.01% 523

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

SIG Brokerage's NMRA Position: Q2 2026 in Review

SIG Brokerage held its Neumora Therapeutics (NMRA) position steady in Q2 2026 at 27,483 shares worth $46.7K. The position accounts for ﹤0.01% of the portfolio, ranked #896.

SIG Brokerage first reported a position in NMRA in Q1 2025 and has held it in 6 quarters since. The position peaked at $64.4K in Q3 2025. 113 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

  • SIG Brokerage held 27,483 shares of Neumora Therapeutics worth $46.7K as of Q2 2026.
  • SIG Brokerage left its Neumora Therapeutics share count unchanged in Q2 2026.
  • Neumora Therapeutics made up ﹤0.01% of SIG Brokerage's portfolio in Q2 2026, its #896 holding.
  • SIG Brokerage first reported a position in Neumora Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • SIG Brokerage's Neumora Therapeutics position peaked at $64.4K in Q3 2025.
  • 113 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on SIG Brokerage's 13F filing for Q2 2026, filed 14 Aug 2026.